Q: I’m taking a GLP-1 to help me control my blood sugar and lose weight. But the cost and side effects of having to do resistance exercise make it difficult ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

They can make or break your experience, and your doctor might not have mentioned them.

The cessation of GLP-1RAs is linked to a 60% weight regain within a year, emphasizing the importance of tailored strategies for effective long-term weight loss.

Three scientists whose work at different stages led to the development of semaglutide – a breakthrough treatment for obesity, diabetes and other cardiometabolic diseases – have been recognised with a ...

Janus Henderson Forty Fund returned 0.27% and the Russell 1000® Growth Index returned 1.12%. U.S. shares rose on positive corporate earnings news. Economic growth has been relatively stable despite a ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

HealthDay News — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online ...